MINI FUTURE OPTIONSSCHEIN PUT - AMGEN | Market Closed - Boerse Frankfurt Warrants 20:34:57 24/05/2024 BST | ||
| 13.87 EUR | +0.14% |
|
| Current month | -19.51% | ||
| 1 month | -19.74% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24/05/24 | 13.82 | -0.22% |
| 23/05/24 | 13.85 | +3.59% |
| 22/05/24 | 13.37 | +2.69% |
| 21/05/24 | 13.02 | -1.06% |
| 20/05/24 | 13.16 | -0.53% |
Real-time Boerse Frankfurt Warrants
Last update May 24, 2024 at 08:34 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ8BFN |
| ISIN | DE000DJ8BFN8 |
| Date issued | 10/01/2024 |
| Strike | 454.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 13.34 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 18.46 € |
|---|---|
| Lowest since issue | 11.99 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
305.8
USD
Average target price
316.3
USD
Spread / Average Target
+3.41%
- Stock Market
- Certificates
- Certificat
